termine the probability of observing the number of tests signifi cant in both ethnic strata by chance alone. Second, we required no signifi cant evidence of heterogeneity of the relationship between the phenotype and the two SNP genotypes across ethnic strata and across fi eld centers within each ethnic group. From this strategy we identifi ed ten pairs of SNPs, involving thirteen SNPs, that displayed statistically signifi cant non-additivity of SNP genotype eff ects on TC. Only one of these thirteen SNPs had statistically signifi cant genotype eff ects that were consistent across samples. Conclusion: Our analyses suggest that ignoring the contribution of interactions between SNP genotype eff ects when modeling multi-SNP genotype-phenotype relationships may result in an underestimate of the contribution of genetic variation to variation in quantitative cardiovascular disease (CVD) risk factor traits.
A4/A5 gene cluster (11q23-24) are involved in lipid metabolism. Apolipoprotein (apo) A-I comprises approximately 70% of the high-density lipoprotein (HDL) particle. It acts as a cofactor of lecithin-cholesterol acyltransferase [2, 3] in facilitating the transport of cholesterol from the peripheral tissues to the liver in a process known as reverse cholesterol transport. ApoC-III is a major component of very low density lipoproteins (VLDL) and chylomicrons. It is thought to play a role in the hepatic uptake of TG-rich particles and their remnants [4] . ApoA-IV has been shown to have a role in lipid absorption, transport and metabolism, as a constituent of HDL and TG-rich lipoprotein particles [5] . Comparisons of human and mouse DNA sequence data have identifi ed the APOA5 gene as a new member of the APOA1/C3/A4 gene cluster [6] . ApoA-V is implicated in regulating lipoprotein lipasemediated VLDL-TG hydrolysis [7] .
Th e statistical associations between variation in plasma levels of HDL-C, TC and TG and single-site and haplotype variations in the APOA1/C3/A4/A5 gene cluster have clearly established the infl uence of these genes in determining phenotypic variability [8] [9] [10] [11] [12] [13] [14] . It is widely acknowledged that gene-gene and gene-environment interaction eff ects also play an important role in the determining levels of these plasma measures of lipid metabolism [15] [16] [17] . Furthermore, the coordinated roles of the genes in this cluster in regulating lipoprotein structure and metabolism suggest that interactions between sites within the gene cluster may make a major contribution to predicting interindividual variation in HDL-C, TC and TG. To investigate this possibility we evaluated the consistency of the infl uence of interactions between pairs of single nucleotide polymorphisms (SNPs) within the APOA1/ C3/A4/A5 gene region on interindividual variation in plasma HDL-C, TC and TG levels in population-based samples of unrelated African-American and EuropeanAmerican males and females.
To identify which SNPs are interacting to infl uence trait variability we used a two-tier analysis strategy. We fi rst required that pairs of SNPs show statistically significant non-additivity of SNP genotype eff ects in both ethnic strata within a gender. Experiment-wise signifi cance was evaluated using a permutation test to determine the probability of observing the number of tests signifi cant in both ethnic strata by chance alone. We chose to consider gender specifi c consistency because of the well-documented gender diff erences in the natural history of the risk of developing CVD [18] and evidence for the gender specifi c genetic architecture of the quantitative CVD risk factors such as blood pressure, obesity and lipid levels [19] . Second, we required that there was no signifi cant evidence of heterogeneity of the phenotype-genotype relationships across ethnic strata and across fi eld centers within each ethnic group. Th e results from these analyses support three conclusions: (1) variations within the APOA1/C3/ A4/A5 gene cluster interact to infl uence interindividual variation in plasma TC levels; (2) the observed pairwise eff ects are not a consequence of linkage disequilibrium (LD) between the SNPs, and (3) ignoring interactions between SNP genotype eff ects when modeling multi-SNP genotype-phenotype relationships may result in underestimating the contribution of genetic variation to quantitative variation in measures of CVD risk.
Methods

Sample and Laboratory Measurements
Th e details of the CARDIA study have been described in Friedman et al. [20] . Th is study consists of unrelated young adults aged 18 to 30 years old who were randomly recruited without regard to health status from residents of Birmingham, Ala., USA, from selected census tracts in Chicago, Ill. and Minneapolis, Minn., USA, and from the membership of the Kaiser-Permanente health plan in Oakland, Calif., USA. Study participants were given a baseline examination (1985) (1986) and venous blood was drawn aft er a 12 h fast. While this is a longitudinal study, only analyses of the baseline data are reported here. Plasma HDL-C, TC and TG levels were determined using standard enzymatic methods [21] .
For the present study, 80 SNPs within the APOA1/C3/A4/A5 gene cluster ( fi g. 1 ) were genotyped in 3,831 individuals (1,075 African-American females, 783 African-American males, 1,041 European-American females and 932 European-American males). Th e gene cluster spans approximately 48 kb and is located on the long arm of chromosome 11q23-q24. 124 SNPs were identifi ed by completely resequencing 17.7 kb that included the intergenic region between APOA1 and APOC3 , the exons, intervening introns and approximately 1000 bp upstream of the APOA1, APOC3, APOA4 and APOA5 genes in 24 unrelated individuals from each of three populations: African-Americans from Jackson, Miss., USA, Europeans from North Karelia, Finland, and EuropeanAmericans from Rochester, Minn., USA [22] . Aft er excluding singletons, insertion/deletion polymorphisms, and one short tandem repeat polymorphism, assays for 80 SNPs were successfully completed using a Sequenom MassARRAY System (San Diego, Calif., USA). Th is assay involves PCR amplifi cation of genomic DNA, a short extension reaction across the polymorphic site and mass spectrometry to detect allele-specifi c mass diff erences of the extension product. Approximately 5% of the samples had a blind duplicate which resulted in approximately 99% agreement between the duplicates and the originals.
Statistical Analyses
Prior to the analyses of phenotype-genotype relationships, TG values were logarithmically (base e) transformed to reduce skewness. Transformation reduced skewness from 2.42 to 0.41 in African-Americans and from 5.04 to 0.68 in European-Americans. Plasma HDL-C, TC and lnTG values were adjusted prior to analysis by fi tting an ethnic/gender/fi eld center-specifi c linear regression model containing age, age 2 , age 3 and body mass index (BMI) and adding the residuals to the ethnic/gender-specifi c mean. Fisher's F test was used to determine whether there was a statistically signifi cant diff erence in the variance of age, height, weight, BMI or plasma HDL-C, TC or lnTG between females and males in each ethnic stratum [23] . Student's t test was used to determine the statistical signifi cance of the diff erence between gender means when the F test was not signifi cant. Satterthwaite's modifi cation of the t test was used when the F test for inequality of the variances was signifi cant [23] . Th e square of the pairwise correlation between SNPs was estimated as
where the composite measure of LD is [24] . p Values for the test of the composite LD( ⌬ AB ) = 0 were obtained using an approximate 2 1 test statistic n 2 AB , where n is the sample size.
Th e one-way analysis of variance was used to test the null hypothesis of additivity of single-SNP genotype mean eff ects. An over-parameterized statistical model was used to estimate and compare average phenotypic values of two-SNP genotypes to determine if there was evidence that single-SNP genotype eff ects combine non-additively to infl uence plasma TC levels [25] . Th is defi nition of non-additivity and its relationship to traditional models of epistasis, as well as a full description of the over-parameterized model applied to genetic data, can be found in Hamon et al. [26] . Briefl y, an over-parameterized general linear model was fi t to two-SNP genotype means and an F statistic, that measures the magnitude of non-additivity, was used to test the statistical significance of deviations from additivity.
Resampling methods were used to determine if there was signifi cant evidence for interaction by creating a test of the null hypothesis that the observed number of signifi cant F tests is not signifi cantly greater than expected by chance sampling. Because the degrees of freedom associated with the F statistic varies among pairs with diff erent numbers of observed genotypes, the p values associated with the F statistics were used to generate the null distribution. Within each ethnic/gender/fi eld center strata the phenotypes were permuted among individuals keeping the two-SNP genotypic structure in each strata fi xed [27] . Th e number of p values that were equal to or less than ␣ = 0.05 level in both ethnic strata of a gender strata was determined for each of 1,000 permutations to create the null distribution of p values [28] . Th e proportion of these p values that exceeded the observed number of p values signifi cant at the ␣ = 0.05 level in both ethnic strata of the gender strata in the analysis of the original data was taken as the experiment-wise level of statistical signifi cance. Table 1 summarizes characteristics of the CARDIA participants included in the present study. Within both ethnic strata, males and females diff ered signifi cantly for mean levels of height, weight, BMI, plasma HDL-C and TG. African-American females had a signifi cantly lower variance for plasma HDL-C and TG and a signifi cantly higher variance for weight and BMI than males, while EuropeanAmerican females had a signifi cantly lower variance for height, plasma TC and TG levels and a signifi cantly higher variance for BMI and plasma HDL-C than males. Th e locations of the 80 SNPs genotyped in this study are shown in fi gure 1 . Of the eight SNPs located in exons, one SNP is located in the 5 UTR, two SNPs resulted in non-synonymous amino acid changes, one SNP was a synonymous change and four SNPs were located in the 3 UTR. Table 2 presents the SNP nomenclature used in this paper, the dbSNP reference where available, the equivalent number used in Fullerton et al. [22] and the polymorphism for each of the 80 SNPs. In order to mitigate the infl uence of multiple testing on the rate of false positives (type I errors), specifi c non-additive SNP genotype eff ects were investigated only if there was a greater number of signifi cant pairwise tests across ethnic strata within a gender than expected under a designated cutoff ( ␣ = 0.05). Table 3 summarizes, separately for each gender, the number of pairs of SNPs for which it is possible to estimate non-additivity in both ethnic strata and the number of tests of these estimates that were signifi cant at the ␣ = 0.05 level of probability in both ethnic strata. Th e corresponding experiment-wise probability of observing at least the number of observed tests signifi cant at the ␣ = 0.05 level of statistical signifi cance in both ethnic strata by chance is given in the last column of table 3 . Th ere was no evidence for an excess in the number of signifi cant tests of non-additivity in both ethnic strata for males or females for HDL-C or lnTG. However, a significant excess (p ^ 0.05) of statistically signifi cant tests was observed for females in the analysis of TC. We observed 14 or more signifi cant tests of non-additivity in both ethnic strata in only 24 of the 1,000 permutation tests (p = 0.024). To further reduce type I errors we required that the phenotype-genotype relationship be maintained across ethnic strata and across fi eld centers within each ethnic group. Specifi cally, we required that there was no significant evidence for heterogeneity of the diff erences among the two-SNP genotype means ( ␣ 1 0.10) across the ethnic strata and across fi eld centers within each of the ethnic strata ( ␣ 1 0.10). Th e ten SNP pairs that satisfi ed these criteria are presented in table 4 . Th ese ten pairs involved 13 SNPs. None of these pairs of SNPs had a signifi cant (p ^ 0.05) non-additive infl uence on plasma HDL-C, TC or lnTG levels in males in both ethnic strata.
Results
When considered separately in a single-SNP analysis only one of the 80 SNPs (16960) had a statistically significant (p ^ 0.05) genotypic eff ect on plasma TC in females in both ethnic strata. Furthermore, it was also the only SNP that had a signifi cant genotypic eff ect on TC levels in both the African-American and European-American samples of males. Th e mean plasma TC level for those individuals with the GG genotype was signifi cantly higher (10 to 20 mg/dl) than those who had AA or AG genotypes in all four ethnic/gender strata (data not shown). Th is single-SNP was involved in one of the ten pairs described above and in table 4 . Th e other nine pairs involved 12 SNPs that did not have signifi cant single-SNP genotypic diff erences in mean TC level. In contrast, diff erences among the means of the two-SNP genotypes defi ned by each of these nine two-SNP pairs ranged from 10 to 50 mg/dl.
Pairwise LD between the 13 SNPs involved in the ten pairs of SNPs identifi ed by our analyses was evaluated to identify multiple signifi cant SNP pairs that may represent a single functional interaction. A summary of the estimates of a composite measure of LD for these 13 SNPs is shown in table 5 . SNPs 01899, 03132 and 03581, are in high LD ( 1 0.75) in both African-Americans and European-Americans suggesting they are marking the same variations in the gene cluster. SNPs 15830 and 16960 are also in high LD in both ethnic strata. Th ese patterns of LD suggest that there are two groups of SNP pairs exhibiting redundant evidence for interaction (group A: 03132-05124 and 03581-05124; group B: 01899-15830 , 03132-15830, 03581-15830 and 03581-16960).
Discussion
Our results establish that there are multiple SNPs within the APOA1/C3/A4/A5 gene cluster that do not have signifi cant genotype eff ects when considered separately, but combine to defi ne two-SNP genotypes that have signifi cant eff ects on plasma TC levels. Th e distribution of these SNPs throughout the gene cluster implicates the involvement of multiple gene regions that are involved in defi ning SNP-SNP interactions. Heterogeneity of the relative frequencies of the two SNP genotypes among samples from diff erent 
Interaction and Marginal Eff ects
Th e approach to modeling epistasis defi ned by Cockerham [29] and the more recent method for estimating physiological epistasis defi ned by Cheverud and Routman [30] cannot be applied in this study because for nearly every pair of SNPs there are missing two-site genotype classes and the relative genotype frequencies of the two SNPs are correlated. As an alternative we chose the Searle method [25] to estimate and compare average phenotype values of two-SNP genotypes to determine if single-SNP genotype eff ects combine non-additively to infl uence variation in trait values.
A common approach in genetic research is to estimate interaction between loci only when there is evidence that each of locus has a statistically signifi cant infl uence on trait variation when considered separately [31, 32] . Culverhouse et al. [33] has shown that variable loci that have b Indicates a statistically signifi cant infl uence on levels of the plasma TC when considered separately in a single-SNP analysis in African-American females at ␣ = 0.05. [26] . Similarly, the number of SNPs in the APOA1/C3/A4/A5 gene cluster that have a signifi cant impact on explaining variation in plasma TC level is underestimated by considering only single-SNP analyses. Only one SNP had a signifi cant impact of plasma TC levels that was consistent in both female samples. Twelve of the 80 SNPs involved in pairwise interactions would not have been considered candidates for marking functional gene variation if only single-SNP analyses were considered. Many of these SNPs only have a signifi cant eff ect in the presence of heterozygosity at a second SNP. Th is is the type of interaction that will not be detected using single-SNP analyses because SNP genotypes have an eff ect in only a subset of the population or opposite and canceling eff ects when in combination with the genotype defi ned by the second SNP. Th ese statistical results are consistent with the experimental fi ndings in yeast [35, 36] , and the working hypothesis that interactions between the eff ects of genetic variants, and between the eff ects of genetic variants and exposures to the environment, not the genetic variants themselves, are the primary causes of phenotypic variability [37] .
Cholesterol Eff ects
Genetic variations in the APOA1/C3/A4/A5 gene cluster have been associated with familial combined hyperlipidemia (FCHL) and therefore have been implicated in infl uencing TC levels [38, 39] . However, an association of TC levels with particular single-site genotypes in the general population has not been consistent across studies [10] . By considering the interactions between SNP eff ects we were able to observe a consistent infl uence of the gene cluster on TC levels in females in both African-American and European-American ethnic strata. Th ese eff ects appear to be independent of the eff ects of variation in the gene cluster on TG and HDL-C, since none of the ten pairs of SNPs had a consistent non-additive infl uence of SNP eff ects on these traits in both ethnic strata. Th e eff ects of non-additivity do not necessarily infl uence a large number of individuals (smallest genotypic class involved four individuals), but the impact of non-additivity on the genotypic value of individuals with these particular two-SNP genotypes may be quite large (diff erences between two-SNP genotypes ranged from 10-50 mg/dl).
SNP Location and Function
Th e 13 SNPs that are involved in the ten pairs that showed signifi cant evidence for interaction in AfricanAmerican and European-American females are located throughout the gene cluster (denoted by shading in fi g. 1 ) suggesting that non-coding regions of the genome may be important for determining phenotypic levels. Nine of the 13 SNPs are located in the APOA1/C3 region. Two of these nine SNPs are located in an intronic region in the APOA1 (01899 and 02110) gene, four (02957, 03132, 03581 and 05124) are located in the intergenic region 3 to the polyadenylation signals in the APOA1 and APOC3 genes, two are located in intronic regions of the APOC3 (06957 and 08143) gene and one is located in the region 5 to the transcription start site of the APOC3 (09154) gene. While the 01899, 02110, 02957, 03132, 03581, 05124, 06957 and 08143 SNPs have not been previously considered in studies of lipid metabolism, other SNPs in the APOA1/C3 intergenic region have been shown to predict FCHL status [40] . None of these SNPs are known to be in regulatory regions, although it has been shown that the APOA1/C3 intragenic region may be involved in regulating these two genes [41] . Levels of HDL-C, TG and apoA-I and risk of developing hypertriglyceridemia have been associated with the 09154 (C-482T) SNP [42] [43] [44] [45] . Th is SNP falls within a functional insulin response element and is located between two other promoter elements in the 5 region of the APOC3 gene [43, 46] . Two of the 13 SNPs were located in the APOA5 gene. One of these (27741) is in the region 5 to the transcription start site and one (29085) is a synonymous polymorphism located in the second exon. Neither of these SNPs has been investigated previously to determine whether they have a signifi cant infl uence on measures of lipid metabolism. Th e remaining two of the 13 SNPs were located in APOA4 . One is a synonymous polymorphism located in the second exon (15830) and one is a non-synonymous substitution in the third exon (16960). Measures of lipid metabolism have not been previously associated with the SNP at location 15830.
Statistical methods applied to population-based data cannot distinguish which SNPs within a gene are responsible for the observed phenotype-genotype associations due to the patterns of LD. Laboratory studies using experimental animal models and biochemical and physiological studies of individuals with particular genotypes have been suggested for sorting out which combinations of SNPs have a biological function and are responsible for the statistical results obtained from a population-based association study. However, such experimental and clinical studies may fall short because they cannot replicate the interaction in the particular genetic and environmental backgrounds that may infl uence the observed phenotype-genotype relationships in the human population at large. In the end, it may be very diffi cult to know with great precision, which SNPs, in which subset of individuals, are biologically responsible for the observed statistical associations.
Population Genetic Structure and Interaction
We required that a pair of SNPs show signifi cant evidence for interaction in both African-American and European-American females to reduce the probability that the observed signifi cance in either strata was due to a type I error. Th e diff erences in relative genotype frequencies between ethnic strata greatly limited our ability to observe consistent evidence of non-additivity. Th eoretically, for 80 SNPs there are 3,160 SNP pairs for which it is possible to estimate interaction. Because of missing classes of genotypes in particular ethnic strata, it was possible to estimate non-additivity of SNP genotype eff ects for only 2,542 pairs of SNPs in African-American females, 1,840 pairs of SNPs in European-American females and 1,586 pairs of SNPs in both strata. Although replication of statistical signifi cance across studies of multiple populations is considered the gold standard for minimizing the probability of committing a type I error, this strategy carries the penalty that it may fail to identify the interaction eff ects that are context-specifi c because the multi-locus genotypes necessary to estimate interaction do not occur in all populations being considered.
Conclusions
In this paper we applied an analytical strategy that identifi ed consistent gender dependent SNP-SNP interaction eff ects. Our application of this strategy illustrates the potential complexity of the phenotype-genotype relationships that must be considered in unraveling the contribution of genetic variation to quantitative variation in risk of a common disease. Non-additivity of gene eff ects may play a major role in determining susceptibility to a common disease having a complex multifactorial etiology because of the ubiquity of biochemical interactions in gene regulation and in the metabolic systems that are involved [47] . Th e statistical interactions we detected may refl ect physical interactions between the coded proteins and biomolecules or may mark molecules that do not interact directly but impact the phenotype non-additively via alternative pathways, although the caveat must be made that the correspondence between statistical interaction and biological interaction is tenuous at best [48, 49] . Th e reality of non-additivity of SNP eff ects calls into question the assumption that any SNP that has a biologically meaningful aff ect on the phenotype must exhibit a statistically signifi cant marginal eff ect. Most SNPs may only have an infl uence on a trait level within a particular genetic background. Th e key to dissecting the genetic architecture of complex traits is to determine the genetic and environmental context in which a SNP has an impact on phenotypic variation. We have shown that multi-SNP A1/C3/A4/A5 genotypes, not a particular single-SNP variation, is the unit of genomic information for predicting an individual's TC level in a particular context indexed by gender. Th e consequences of ignoring the genetic background in which a SNP infl uences a quantitative trait could be a serious bias in the incorporation of genomic information into strategies for developing personalized medical approaches to the diagnosis and treatment of common diseases having a complex multifactorial etiology.
